Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

CUSIP: 69012T305

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
120,049,038
Total 13F shares
34,194
Share change
0
Total reported value
$59,498
Price per share
$1.74
Number of holders
1

Quarterly Holders Quick Answers

What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Arun Kumar Pillai
3/4/5
Director, 10%+ Owner
class O/S missing
22,982,529
$26,085,170 01 Feb 2022
Tenshi Healthcare Pte. Ltd.
3/4/5
10%+ Owner
class O/S missing
22,982,529
$26,085,170 21 Apr 2022
BlackRock Finance, Inc.
13F
Company
class O/S missing
8,067,428
$8,793,496 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
6,010,537
$6,551,485 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
2,537,675
$2,766,065 31 Mar 2023
13F
STATE STREET CORP
13F
Company
class O/S missing
2,020,052
$2,201,857 31 Mar 2023
13F
LVW Advisors, LLC
13F
Company
class O/S missing
1,733,633
$1,889,660 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
1,202,387
$1,310,601 31 Mar 2023
13F
Nuveen Asset Management, LLC
13F
Company
class O/S missing
855,655
$933,000 31 Mar 2023
13F
Terry Dagnon
3/4/5
Chief Operations Officer
mixed-class rows
845,201
mixed-class rows
$741,221 20 Apr 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
class O/S missing
515,483
$562,000 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
class O/S missing
421,588
$459,531 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
class O/S missing
412,273
$449,378 31 Mar 2023
13F
VISTA FINANCE, LLC
13F
Company
class O/S missing
217,640
$237,228 31 Mar 2023
13F
LINCOLN NATIONAL CORP
13F
Company
class O/S missing
194,300
$211,787 31 Mar 2023
13F
RHUMBLINE ADVISERS
13F
Company
class O/S missing
178,341
$194,000 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
168,397
$183,553 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
class O/S missing
160,721
$175,186 31 Mar 2023
13F
FIRST MERCHANTS CORP
13F
Company
class O/S missing
149,170
$161,103 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
127,477
$138,950 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
118,474
$129,000 31 Mar 2023
13F
Ancora Advisors LLC
13F
Company
class O/S missing
108,500
$118,265 31 Mar 2023
13F
LPL Financial LLC
13F
Company
class O/S missing
101,200
$110,308 31 Mar 2023
13F
DEUTSCHE BANK AG\
13F
Company
class O/S missing
99,258
$108,191 31 Mar 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
class O/S missing
97,839
$107,000 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
90,657
$98,816 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
88,393
$96,348 31 Mar 2023
13F
MetLife Investment Management, LLC
13F
Company
class O/S missing
83,435
$90,944 31 Mar 2023
13F
BARCLAYS PLC
13F
Company
class O/S missing
79,190
$86,317 31 Mar 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
class O/S missing
74,641
$81,359 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
71,022
$77,414 31 Mar 2023
13F
MSH Capital Advisors LLC
13F
Company
class O/S missing
68,166
$74,301 31 Mar 2023
13F
GABLES CAPITAL MANAGEMENT INC.
13F
Company
class O/S missing
66,500
$72,485 31 Mar 2023
13F
Squarepoint Ops LLC
13F
Company
class O/S missing
65,140
$71,003 31 Mar 2023
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
64,880
$70,719 31 Mar 2023
13F
SG Americas Securities, LLC
13F
Company
class O/S missing
61,941
$68,000 31 Mar 2023
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
class O/S missing
60,737
$66,203 31 Mar 2023
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
class O/S missing
57,500
$62,675 31 Mar 2023
13F
Flower City Capital
13F
Company
class O/S missing
54,010
$58,871 31 Mar 2023
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
class O/S missing
50,684
$55,246 31 Mar 2023
13F
PPS&V ASSET MANAGEMENT CONSULTANTS, INC.
13F
Company
class O/S missing
50,153
$54,667 31 Mar 2023
13F
Corient Private Wealth LLC
13F
Company
class O/S missing
49,000
$53,410 31 Mar 2023
13F
Invesco Ltd.
13F
Company
class O/S missing
47,521
$51,798 31 Mar 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
class O/S missing
43,900
$47,851 31 Mar 2023
13F
PVG ASSET MANAGEMENT CORP
13F
Company
class O/S missing
42,270
$46,074 31 Mar 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
class O/S missing
35,920
$39,153 31 Mar 2023
13F
Focus Financial Network, Inc.
13F
Company
0.03%
34,194
$37,271 31 Mar 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
class O/S missing
29,212
$32,000 31 Mar 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
class O/S missing
26,522
$28,000 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
23,546
$26,000 31 Mar 2023
13F

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q2 2023

As of 30 Jun 2023, Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 34,194 shares. The largest 1 holders included Focus Financial Network, Inc.. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
1
Q2 2023 holders
1
Holder diff
0
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.